Quality Improvement Initiatives in Inflammatory Bowel Disease

被引：12

作者：

Berry S.K. ^{[1
]}

Siegel C.A. ^{[2
]}

Melmed G.Y. ^{[1
,3
]}

机构：

[1] Department of Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, 90048, CA

[2] Department of Medicine, Dartmouth-Hitchcock Medical Center, 1 Medical Center Dr, Lebanon, 03766, NH

[3] Inflammatory Bowel Disease Center, 8730 Alden Drive, Second Floor East, Los Angeles, 90048, CA

来源：

Current Gastroenterology Reports | 2017年 / 19卷 / 8期

关键词：

Gastroenterology; Inflammatory bowel disease; Learning health system; Quality improvement; Quality measures; Specialty medical home;

D O I：

10.1007/s11894-017-0581-x

中图分类号：

学科分类号：

摘要：

Purpose of Review: This article serves as an overview of several quality improvement initiatives in inflammatory bowel disease (IBD). Recent Findings: IBD is associated with significant variation in care, suggesting poor quality of care. There have been several efforts to improve the quality of care for patients with IBD. Quality improvement (QI) initiatives in IBD are intended to be patient-centric, improve outcomes for individuals and populations, and reduce costs—all consistent with “the triple aim” put forth by the Institute for Healthcare Improvement (IHI). Summary: Current QI initiatives include the development of quality measure sets to standardize processes and outcomes, learning health systems to foster collaborative improvement, and patient-centered medical homes specific to patients with IBD in shared risk models of care. Some of these programs have demonstrated early success in improving patient outcomes, reducing costs, improving patient satisfaction, and facilitating patient engagement. However, further studies are needed to evaluate and compare the effects of these programs over time on clinical outcomes in order to demonstrate long-term value and sustainability. © 2017, Springer Science+Business Media, LLC.

引用

共 22 条

[1]

Report: economic implications of inflammatory bowel disease and its management. Am J Manag Care, (2016)

[2]

Altschuler A., Collins B., Lewis J.D., Velayos F., Allison J.E., Hutfless S., Et al., Gastroenterologists’ attitudes and self-reported practices regarding inflammatory bowel disease, Inflamm Bowel Dis, 14, pp. 992-999, (2008)

[3]

Weaver K.N., Kappelman M.D., Sandler R.S., Variation in care of inflammatory bowel diseases patients in Crohnʼs and Colitis Foundation of America Partners, Inflamm Bowel Dis, 22, 11, pp. 2672-2677, (2016)

[4]

Spiegel B.M.R., Ho W., Esrailian E., Targan S., Higgins P.D.R., Siegel C.A., Et al., Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists, Clin Gastroenterol Hepatol, 7, pp. 168-174, (2009)

[5]

Kappelman M.D., Bousvaros A., Hyams J., Markowitz J., Pfefferkorn M., Kugathasan S., Et al., Intercenter variation in initial management of children with Crohn’s disease, Inflamm Bowel Dis, 13, pp. 890-895, (2007)

[6]

Crandall W.V., Margolis P.A., Kappelman M.D., King E.C., Pratt J.M., Boyle B.M., Et al., Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease, Pediatrics, 129, pp. e1030-e1041, (2012)

[7]

Kaplan G.G., McCarthy E.P., Ayanian J.Z., Korzenik J., Hodin R., Sands B.E., Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis, Gastroenterology, 134, pp. 680-687, (2008)

[8]

Ananthakrishnan A.N., McGinley E.L., Binion D.G., Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume, Am. J. Gastroenterol, 103, pp. 2789-2798, (2008)

[9]

Aim T.I.H.I.T., Dec 26], Available from:, (2016)

[10]

Melmed G.Y., Siegel C.A., Spiegel B.M., Allen J.I., Cima R., Colombel J.F., Dassopoulos T., Denson L.A., Dudley-Brown S., Garb A., Hanauer S.B., Kappelman M.D., Lewis J.D., Lynch I., Moynihan A., Rubin D.T., Sartor R.B., Schwartz R.M., Wolf D.C., Ullman T.A., Quality indicators for inflammatory bowel disease: development of process and outcome measures, Inflamm Bowel Dis, 19, 3, pp. 662-668, (2013)

← 1 2 3 →